You are here: Home 
Categories Prostate Cancer
Categories Prostate Cancer Combining PSA testing with novel drug therapy helps doctors identify hard-to-diagnose prostate cancer
Combining PSA testing with novel drug therapy helps doctors identify hard-to-diagnose prostate cancer
Published on 09 August 2012
NEW YORK, NY USA (Press Release) - August 9, 2012 - Researchers have successfully developed and tested a new prostate cancer screening method that uses the combined power of a novel drug therapy and changes in PSA levels over time to identify men with a high PSA who are more likely to have aggressive prostate cancer despite negative biopsies.
To read more, a FREE Urotoday registration is required. Click here to register or login above.To read UIJ content, a separate subscription is required.
Tags:
